Particula | $5,500,000 | (May 1, 2025)
Stimuler | $3,750,000 | (May 1, 2025)
SpriveApp | $7,300,000 | (May 1, 2025)
Poppins
France
- Paris, Île-de-France
- 29/04/2025
- Unknown
- $5,697,525
Poppins, at the intersection of music, education and health, develops tools for therapeutic continuity for children with neurodevelopmental disorders, particularly dys disorders. Built around rhythmic and auditory stimuli (applicable to many neurodevelopmental pathologies), we have a strong use of music thanks to our partners (Warner / Disney / Sony...), to create a rich, non-medicated and non-stigmatizing experience for the child.
Our job is to work alongside health professionals by accompanying the child in his or her therapeutic journey at home.
Poppins was founded at École Polytechnique in 2018 and has grown in France and Los Angeles (Techstars US). As a partner of the French Federation of Learning Disorders, we have been able to accompany more than 15000 young children with learning disabilities.
- Industry Medical Equipment Manufacturing
- Website https://www.poppins.io/
- LinkedIn https://www.linkedin.com/company/wearepoppins/
Manifest | $15,000,000 | (May 1, 2025)
Spark Biomedical Inc | $15,000,000 | (May 1, 2025)
Queens Carbon | $10,000,000 | (May 1, 2025)
Noma Therapy | $4,250,000 | (May 1, 2025)
Persona | $200,000,000 | (May 1, 2025)
Nuvo | $45,000,000 | (May 1, 2025)
Pallie | $2,000,000 | (May 1, 2025)
Faye(US) | $2,500,000 | (May 1, 2025)
Structify | $4,100,000 | (May 1, 2025)